13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001274413
Total reported value
$143.3M
$143.3M
84 檔
35.7%
At the close of Q1 2025, Sectoral Asset Management Inc disclosed equity holdings valued at approximately $143.3M, spread across 84 reported holdings.
In Q1 2025, Sectoral Asset Management Inc displayed an active expansion posture, initiating 84 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LENZ | Lenz Therapeutics Inc | Stock-Other | 19.56% | — | — | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 6.05% | +0.48% | -24.95% | |
| 3 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 5.26% | +0.49% | -11.83% | |
| 4 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 4.58% | -0.47% | -2.72% | |
| 5 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 4.35% | +0.45% | — | |
| 6 | JNJ | Johnson & Johnson | Stock-Healthcare | 2.81% | -0.46% | -4.80% | |
| 7 | GILD | Gilead Sciences Inc | Stock-Healthcare | 2.79% | -1.60% | -37.59% | |
| 8 | AMGN | Amgen Inc | Stock-Healthcare | 2.52% | -0.58% | -17.25% | |
| 9 | ABBV | Abbvie Inc | Stock-Healthcare | 2.41% | -0.06% | -21.28% | |
| 10 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 2.02% | -0.38% | +72.13% | |
| 11 | ABT | Abbott Laboratories | Stock-Healthcare | 1.93% | -1.04% | -23.36% | |
| 12 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.90% | -0.73% | -25.52% | |
| 13 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.88% | -0.20% | +9.80% | |
| 14 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.78% | -0.98% | +28.75% | |
| 15 | SYK | Stryker CORP | Stock-Healthcare | 1.77% | -0.03% | -4.69% | |
| 16 | DHR | Danaher CORP | Stock-Healthcare | 1.69% | -0.23% | +45.36% | |
| 17 | MDT | Medtronic plc | Stock-Healthcare | 1.67% | -0.19% | -9.49% | |
| 18 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.43% | -0.44% | -9.53% | |
| 19 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.37% | -1.12% | -18.44% | |
| 20 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.29% | -0.12% | -19.97% | |
| 21 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.26% | -0.20% | -31.58% | |
| 22 | BNTX | Biontech Se-adr | Stock-Other | 1.22% | +1.03% | -9.37% | |
| 23 | PFE | Pfizer Inc | Stock-Healthcare | 1.18% | -0.18% | -23.18% | |
| 24 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.09% | -0.23% | -37.29% | |
| 25 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.07% | — | +28.26% | |
| 26 | SMMT | Summit Therapeutics Inc | Stock-Other | 1.04% | +1.08% | +130.80% | |
| 27 | SPRY | Ars Pharmaceuticals Inc | Stock-Other | 0.98% | -0.39% | -5.47% | |
| 28 | LEGN | Legend Biotech Corp-adr | Stock-Other | 0.95% | — | +20.69% | |
| 29 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.94% | — | — | |
| 30 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.93% | -0.21% | -55.68% | |
| 31 | INSM | Insmed Inc | Stock-Healthcare | 0.90% | -1.07% | +106.62% | |
| 32 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 0.87% | — | +360.45% | |
| 33 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.84% | — | -33.21% | |
| 34 | BOLD | Boundless Bio Inc | Stock-Other | 0.80% | -0.62% | EXIT | |
| 35 | DXCM | Dexcom Inc | Stock-Healthcare | 0.80% | +1.18% | — | |
| 36 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.77% | — | -10.55% | |
| 37 | RDNT | Radnet Inc | Stock-Healthcare | 0.77% | -0.37% | EXIT | |
| 38 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.69% | -0.13% | -15.02% | |
| 39 | AM6 | Amicus Therapeutics Inc | Stock-Other | 0.68% | — | -20.67% | |
| 40 | PHR | Phreesia Inc | Stock-Other | 0.68% | — | — | |
| 41 | CVRX | Cvrx Inc | Stock-Other | 0.65% | — | — | |
| 42 | ONC | Beone Medicines Ltd-adr | Stock-Other | 0.62% | -0.15% | +45.62% | |
| 43 | PCVX | Vaxcyte Inc | Stock-Other | 0.62% | — | +11.03% | |
| 44 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.57% | +0.52% | -26.25% | |
| 45 | ICLR | ICON Public Limited Company | Stock-Healthcare | 0.54% | — | — | |
| 46 | VERA | Vera Therapeutics Inc | Stock-Other | 0.53% | -0.13% | +397.33% | |
| 47 | CLOV | Clover Health Investments Co | Stock-Other | 0.51% | — | -33.45% | |
| 48 | ELV | Elevance Health Inc | Stock-Healthcare | 0.51% | — | — | |
| 49 | QURE | uniQure N.V. | Stock-Other | 0.47% | -0.41% | EXIT | |
| 50 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.46% | — | -36.22% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LENZ | Lenz Therapeutics Inc | — | NEW | New buy |
| 2 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 3 | UNH | Unitedhealth Group Inc | — | NEW | New buy |
| 4 | MLYS | Mineralys Therapeutics Inc | — | NEW | New buy |
| 5 | CTNM | Contineum Therapeutics Inc-a | — | NEW | New buy |
| 6 | JNJ | Johnson & Johnson | — | NEW | New buy |
| 7 | GILD | Gilead Sciences Inc | — | NEW | New buy |
| 8 | AMGN | Amgen Inc | — | NEW | New buy |
| 9 | ABBV | Abbvie Inc | — | NEW | New buy |
| 10 | ISRG | Intuitive Surgical Inc | — | NEW | New buy |
| 11 | ABT | Abbott Laboratories | — | NEW | New buy |
| 12 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 13 | MRK | Merck & Co. Inc. | — | NEW | New buy |
| 14 | VRTX | Vertex Pharmaceuticals Inc | — | NEW | New buy |
| 15 | SYK | Stryker CORP | — | NEW | New buy |
| 16 | DHR | Danaher CORP | — | NEW | New buy |
| 17 | MDT | Medtronic plc | — | NEW | New buy |
| 18 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 19 | REGN | Regeneron Pharmaceuticals | — | NEW | New buy |
| 20 | BMRN | Biomarin Pharmaceutical Inc | — | NEW | New buy |
| 21 | TMO | Thermo Fisher Scientific Inc | — | NEW | New buy |
| 22 | BNTX | Biontech Se-adr | — | NEW | New buy |
| 23 | PFE | Pfizer Inc | — | NEW | New buy |
| 24 | ALNY | Alnylam Pharmaceuticals Inc | — | NEW | New buy |
| 25 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 26 | SMMT | Summit Therapeutics Inc | — | NEW | New buy |
| 27 | SPRY | Ars Pharmaceuticals Inc | — | NEW | New buy |
| 28 | LEGN | Legend Biotech Corp-adr | — | NEW | New buy |
| 29 | THC | Tenet Healthcare CORP | — | NEW | New buy |
| 30 | BMY | Bristol-myers Squibb Co | — | NEW | New buy |
| 31 | INSM | Insmed Inc | — | NEW | New buy |
| 32 | SWTXUSD | Springworks Therapeutics Inc | — | NEW | New buy |
| 33 | ZLAB | Zai Lab Ltd-adr | — | NEW | New buy |
| 34 | BOLD | Boundless Bio Inc | — | NEW | New buy |
| 35 | DXCM | Dexcom Inc | — | NEW | New buy |
| 36 | 2655787D | Blueprint Medicines CORP | — | NEW | New buy |
| 37 | RDNT | Radnet Inc | — | NEW | New buy |
| 38 | TARS | Tarsus Pharmaceuticals Inc | — | NEW | New buy |
| 39 | AM6 | Amicus Therapeutics Inc | — | NEW | New buy |
| 40 | PHR | Phreesia Inc | — | NEW | New buy |
| 41 | CVRX | Cvrx Inc | — | NEW | New buy |
| 42 | ONC | Beone Medicines Ltd-adr | — | NEW | New buy |
| 43 | PCVX | Vaxcyte Inc | — | NEW | New buy |
| 44 | CYTK | Cytokinetics Inc | — | NEW | New buy |
| 45 | ICLR | ICON Public Limited Company | — | NEW | New buy |
| 46 | VERA | Vera Therapeutics Inc | — | NEW | New buy |
| 47 | CLOV | Clover Health Investments Co | — | NEW | New buy |
| 48 | ELV | Elevance Health Inc | — | NEW | New buy |
| 49 | QURE | uniQure N.V. | — | NEW | New buy |
| 50 | MLTX | Moonlake Immunotherapeutics | — | NEW | New buy |
According to official SEC Form 13F filings, Sectoral Asset Management Inc reported a total U.S. public equity portfolio value of $143.3M across 84 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LENZ, LLY, UNH) accounted for 35.7% of total reported equity market value during Q1 2025.
Top New Position Initiated
LENZ
市值: $25.1M
During Q1 2025, Sectoral Asset Management Inc's top holdings by market value included LENZ (19.6%)、LLY (6.0%)、UNH (5.3%). The largest single position, LENZ, represented 19.6% of total portfolio value.
In Q1 2025, Sectoral Asset Management Inc made 84 total portfolio adjustments, initiating 84 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.